The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Accelmed Partners Ii L.p. since 2021.
This trader's CIK number is 1807256.
At the time of last reporting, Accelmed Partners Ii L.p. was the 10% Owner of Neuropace Inc. (stock ticker symbol NPCE).
Also see all insider trading activities at Neuropace Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | NPCE | 390,291 | $585,045 | 0 | $0 | 0 | $0 |
| 2021 | NPCE | 588,235 | $9,999,995 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-11-22 | NPCE | Buy | 62,398 | 1.50 | 93,534 |
| 2022-11-21 | NPCE | Buy | 327,893 | 1.50 | 491,511 |
| 2021-04-21 | NPCE | Buy | 588,235 | 17.00 | 9,999,995 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Accelmed Partners Ii L.p. (10% Owner of Neuropace Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.